MedPath

Triosaph

Brand Name: Triosaph

Generic Name: Rifampicin + Isoniazid + Ethambutol Hydrochloride

Active
Registration Number

DRP-13108

Dosage Form

Film-Coated Tablet

Issuance Date

December 1, 2022

Expiry Date

December 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength150 mg/75 mg/ 300 mg
PackagingAlu/Red PVC Blister Pack x 4's (Box of 100's); Alu/Red PVC Blister Pack x 10's (Box of 100's); Alu/Red PVC Blister Pack x 28's (Box of 84's).

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (3)

Complete list of active ingredients in this pharmaceutical product.

RifampicinActive
Monograph: Rifampicin
IsoniazidActive
Monograph: Isoniazid
Ethambutol HydrochlorideActive
Monograph: Ethambutol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform